Page 2 - index
P. 2
Continued from page 01
Position the Laboratory
for Molecular Testing NOW
Four factors will drive the What are the advantages
continued growth of MDx testing: of MDx testing?
REIMBURSEMENT RESOLUTION CLEAR FDA GUIDANCE Molecular genetics has progressed since 2002 and is no
regulating CPT codes for proposing new policies longer restricted to academic or reference laboratory settings.
proper reimbursement and regulations Hospitals doing MDx testing are profiting from in-house testing
and are enjoying the benefits of faster turnaround times, greater
PHARMACOGENOMICS POINT-OF-CARE TESTING and improved sensitivities, accuracy, and cost savings from not
continuing the market trend advancing next-generation sending out to reference laboratories.
with genetics discoveries technology for genetic testing Technology will continue to drive this industry.
Those who wait will be at a disadvantage.
RCM Enterprise Services, Inc. | A Revenue Cycle Management Company
